Clinical Trial Update: Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating ursodiol with a chemotherapy regimen and bevacizumab in Stage IV colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• URSODIOL (ursodiol)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED